Home » BG Medicine Files for Expanded Indication of BGM Galectin-3 Test
BG Medicine Files for Expanded Indication of BGM Galectin-3 Test
BG Medicine has filed 510(k) premarket notification for regulatory clearance of an expanded indication for its BGM Galectin-3 test with the FDA.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May